Inactivation of PBX3 and HOXA9 by down-regulating H3K79 methylation represses NPM1-mutated leukemic cell survival | |
Zhang, Wu; Zhao, Chen; Zhao, Junmei; Zhu, Yongmei; Weng, Xiangqin; Chen, Qiusheng; Sun, Huiping; Mi, Jian-Qing; Li, Junmin; Zhu, Jiang | |
刊名 | THERANOSTICS
![]() |
2018 | |
卷号 | 8期号:16 |
关键词 | NPM1 mutation H3K79 hypermethylation PBX3 HOXA9 DOT1L inhibitor |
ISSN号 | 1838-7640 |
DOI | 10.7150/thno.26900 |
URL标识 | 查看原文 |
收录类别 | SCIE |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4155466 |
专题 | 武汉大学 |
推荐引用方式 GB/T 7714 | Zhang, Wu,Zhao, Chen,Zhao, Junmei,et al. Inactivation of PBX3 and HOXA9 by down-regulating H3K79 methylation represses NPM1-mutated leukemic cell survival[J]. THERANOSTICS,2018,8(16). |
APA | Zhang, Wu.,Zhao, Chen.,Zhao, Junmei.,Zhu, Yongmei.,Weng, Xiangqin.,...&Xu, Jie.(2018).Inactivation of PBX3 and HOXA9 by down-regulating H3K79 methylation represses NPM1-mutated leukemic cell survival.THERANOSTICS,8(16). |
MLA | Zhang, Wu,et al."Inactivation of PBX3 and HOXA9 by down-regulating H3K79 methylation represses NPM1-mutated leukemic cell survival".THERANOSTICS 8.16(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论